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A major challenge in the production of 3D tissue engineered skin is the recreation of the base-
ment membrane region to promote secure attachment and yet segregation of keratinocytes from
the dermal substitute impregnated with fibroblasts. We have previously shown that simple electro-
spun scaffolds provide fibres on which the cells attach, proliferate, and self-sort into epithelium and
dermis. In a development of this in this study tri-layered scaffolds were then electrospun from poly
L-lactic acid and poly hydroxybutyrate-co-hydroxyvalerate. In these a central layer of the scaffolds
comprising nano-porous/nano-fibrous poly hydroxybutyrate-co-hydroxyvalerate fibres was interwo-
ven into the bulk micro-porous poly L-lactic acid microfibers to mimic the basement membrane.
Keratinocytes and fibroblasts seeded onto these scaffolds and cultured for 2 weeks showed that
neither cell type was able to cross the central nano-porous barrier (shown by SEM, and fluores-
cence monitoring with CellTracker™) while the micro-fibrous poly L-lactic acid provided a scaffold
on which keratinocytes could create an epithelium and fibroblasts could create a dermal substitute
depositing collagen. Although cells did not penetrate this barrier the interaction of cells was still
evident-essential for epithelial development.
Keywords:
1. INTRODUCTION
There has been an increasing interest in the tissue engi-
neering of skins using natural or synthetic matrices for
treatment of burns and other skin injuries to restore bar-
rier function or to initiate wound healing.1 Such a tissue
engineering approach can potentially remove the funda-
mental limitation of skin repair-the lack of sufficient suit-
able donor material. Tissue-engineered skin is created by
harvesting and expanding appropriate skin cells, seed-
ing them into a three-dimensional scaffold and induc-
ing them to proliferate, differentiate and develop into a
tissue for implantation. Skin comprises several different
cell types which reside on and in the dermis respec-
tively. Keratinocytes are the most common cell type in the
epidermis, forming a proliferative layer of dividing cells
attached to the basement membrane of the papillary der-
mis. Supra-basal keratinocytes stratify and differentiate to
form the surface cornified lipid rich barrier layer. Fibrob-
lasts reside within the collagen/fibrin matrix of the dermis
∗Author to whom correspondence should be addressed.
and are crucial in both matrix repair and renewal, but the
cytokine interplay between fibroblasts and keratinocytes is
required for the successful creation of a functional normal
epidermis.2 The dermal matrix which supports the epi-
dermis provides mechanical support, strength, flexibility
and elasticity for the skin. Its upper papillary surface pro-
vides basement membrane allowing strong attachment and
promotion of proliferation for keratinocytes.34 Its matrix
provides the ECM carrying capillaries supplying nutri-
tion to the epithelium and waste removal and immune
surveillance in addition to sweat glands and anchorage for
hair follicles. The basement membrane is a dense, highly
cross-linked sheet of extracellular matrix that structurally
underlies all epithelia, it is selectively permeable to the
cells of the skin-segregating keratinocytes and fibroblasts
at the dermal/epidermal junction.5–7 In 2D and 3D cul-
ture systems where rapid keratinocyte growth is promoted,
keratinocytes not only inhibit fibroblast proliferation, but
can detach fibroblasts from the surface on which they are
growing-removing them despite their contribution to ker-
atinocyte growth and development.
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The dermis is anything but a simple scaffold, and the
development of a scaffold to replace it–even during short
term wound healing requires a scaffold to perform at least
some of the basic functions of dermis. Scaffolds should
be biocompatible and exhibit mechanical properties simi-
lar to those of target tissue. Moreover, the scaffold should
have structural and properties mimicking those of the der-
mis supporting cell behaviour such as adhesion, migration,
proliferation, and differentiation.8
Artificial basement membrane regions in tissue engi-
neered models are not common due to the complex nature
of the proteins involved, though the use of the animal
tumour derived matrix extract known as matrigel can pro-
vide some of the functionality of a BM.9–11 Where ker-
atinocytes and fibroblasts are cultured separately on an
appropriate matrix such as a collagen/fibrin gel they can
recreate a functional basement membrane though this takes
a significant time, and is mechanically weak compared to
skin.12
Electrospinning is a popular and versatile method for
producing scaffolds for 3D tissue engineering and regen-
erative medicine, and it can give 3D open porous struc-
tures which approximate to the structure of the dermis.13–16
The use of synthetic scaffolds avoids the potential disease
transmission associated with native tissues such as bovine
collagen but in common with other synthetic scaffolds a
monolith of fibres gives no barrier or partition of the epi-
dermal and stromal cells.17 Bye et al. created bi- and tri-
layer scaffolds of micro-porous poly L-lactic acid (PLLA)
electrospun onto nano-porous poly hydroxybutyrate-co-
hydroxyvalerate (PHBV) scaffolds-creating a cell imper-
meable sheet coated on one or both sides with a
micro-porous scaffold capable of segregating cells and
supporting growth. In these early experiments delamina-
tion of the nano-porous layer from the micro-porous layer
was a potential issue.18 We have further developed this
scaffold so that the nano-porous layer can be interwo-
ven within a PLLA micro-porous scaffold. The PHBV and
PLLA fibres co-mingle as a central cell impermeable layer
to provide segregation and to prevent delamination.
In this study the potential of the nano-fibrous PHBV
membrane of the tri-layered scaffold to act as a surrogate
basement membrane was investigated by seeding these tri-
layered scaffolds with human epithelial keratinocytes and
dermal fibroblasts and assessing the maintenance of seg-
regation. Such a tissue construct may be of use as both
a research model and as a tissue engineered replacement
for split-thickness skin when constructed with the patient’s
own laboratory expanded skin cells.
2. METHODS
2.1. Preparation of Electrospun Scaffolds
Micro-fibrous PLLA and nano-fibrous PHBV scaffolds
were electrospun using parameters as described by Bye
et al.19 PLLA (10 wt% solution in Dichloromethane
(DCM) and PHBV (10 wt% solution in 90 wt% DCM/
10 wt% methanol) was pumped from 4 syringes at
40  L min−1 per syringe. For PLLA a needle to collector
distance of 17 cm was used while for PHBV, a distance
of 10 cm was used. The syringe needles were charged to
+17 kV (73030 P, Genvolt, Shropshire, UK) and poly-
mer solutions spun onto an earthed rotating (400 RPM)
aluminium foil coated mandrel (20 cm wide, 10 cm diam-
eter) (Fig. 1(A)). PLLA and PHBV were setup in separate
syringe pumps on either side of the rotating mandrel and
charged by individual power supplies. Tri-layers were spun
by sequentially spinning first 8 ml PLLA, 4 ml of PHBV
was simultaneously spun with 4 ml PLLA from a matching
spinning setup on the other side of the mandrel then 8 ml
PLLA was spun alone, creating a PLLA-PHBV/PLLA-
PLLA tri-layer construct. A PLLA monolayer scaffold was
electrospun by repeating this method but omitting the spin-
ning of PHBV.
2.2. Tissue Engineered Skin Culture
on PLLA/PHBV Scaffolds
Human keratinocytes and fibroblasts were obtained from
split thickness skin grafts taken from skin obtained from
elective breast reductions or abdominoplasties with fully
informed consent and stored under HTA Tissue Bank
license no 12179.
Skin was cut into 5× 5 mm pieces and digested in
trypsin solution (1 mg ·mL−1 porcine trypsin, 0.1% w/v
D-glucose in PBS) for 18 hours at 4 C. Keratinocytes
were then gently scraped from the dermal-epidermal junc-
tion region into Green’s medium (Dulbecco’s modified
Eagle’s medium (DMEM) and Ham’s F12 medium in a 3:1
(v/v) ratio supplemented with 10% (v/v) fetal calf serum
(FCS), 01 M cholera toxin, 10 ng/ml epidermal growth
factor (EGF), 04 g/ml hydrocortisone, 0.18 mM adenine,
5 g/ml insulin, 2 mM glutamine, 02 M triiodothyro-
nine, 0625 g/ml amphotericin B, 100 IU/ml penicillin
and 100 g/ml streptomycin) after. Keratinocytes were co-
cultured with an i3T3 feeder layer prior to use and passage
1-2 keratinocytes were used in experiments.
Fibroblasts were isolated from de-epithelialised dermis
by collagenase digestion (0.1% collagenase in DMEM)
overnight at 37 C. After pelleting the cells at 400 g
for 10 mins, fibroblasts were cultured in DMEM (supple-
mented with 10% v/v FCS and 0625 g/ml amphotericin
B, 100 IU/ml penicillin and 100 g/ml streptomycin and
2 mM glutamine), and passage 4–9 fibroblasts were used
in experiments.
Tri-layer (PLLA-PHBV/PLLA-PLLA) and monolayer
(PLLA) electrospun scaffolds (2 cm×2 cm) were sterilised
(70% v/v ethanol in dH2O) for 10 mins, washed with PBS,
and placed in 6-well plates. A 1 cm diameter culture well
was formed on the scaffold using a 1 cm diameter stainless
steel ring and 1×105 fibroblasts (in DMEM supplemented
with 10% FCS v/v) seeded inside. Constructs were cul-
tured for 2 days at 37 C and 5% CO2. Scaffolds were
2 J. Biomater. Tissue Eng. 4, 1–7, 2014
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them turned over and 3× 105 keratinocytes were seeded
onto each scaffold in Green’s medium. After a further 2
days of culture the constructs were raised to an air–liquid
interface on stainless steel grids and cultured for a further
7 and 14 days.
2.3. Scanning Electron Microscopy (SEM) of Scaffolds
Constructs were removed from culture medium, washed
briefly with PBS then fixed in 2.5% glutaraldehyde for
10 minutes. The specimens were then incubated with 2 ml
of 0.1 M sodium cacodylate buffer for 3–5 minutes then in
2 ml of 2.5% glutaraldehyde for 30 mins. Each sample was
then rinsed with sodium cacodylate buffer to remove any
remaining glutaraldehyde. Secondary fixation was carried
out in 2% osmium tetroxide (aqueous) for 2 hours before
incubation in 2 ml of 0.1 M sodium cacodylate buffer for
15 min. Samples were then dehydrated in ascending grades
of alcohol then dried overnight, bisected and mounted on
12.5 mm stubs. Samples were then sputter coated with
gold (25 nm thick approximately) then examined using a
scanning electron microscope (FEI XL-20 SEM, Philips,
Guildford, UK) at an accelerating voltage of 20 kV.
2.4. Assessment of Viability of Tissue Engineered Skin
Viable cell density of tissue engineered skin was assessed
using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide) Eluted Stain Assay (MTT-ESTA).
Intracellular dehydrogenase activity reduces MTT to a pur-
ple coloured formazan salt. In healthy viable cells, MTT
is reduced to a purple coloured formazan salt by the activ-
ity of the mitochondrial enzyme succinyl dehydrogenase.
Electrospun scaffolds with the cells cultured for 7 and
14 days were washed three times in PBS and then incu-
bated with MTT solution (0.5 mg/ml MTT in PBS, 2 ml
per well of 6-well plate) for 45 min at 37 C and in a
95% air/5% CO2 environment. After 45 min samples were
washed with PBS, and the samples incubated in 100 l
Cellusolve™ for 10 min. The optical density at 540 nm
(with a reference at 630 nm) was then measured using
a spectrophotometer (Bio-TEK, NorthStar Scientific LTD,
Leeds, UK).
2.5. Quantification of Collagen Deposition in Scaffolds
Collagen deposition on scaffold fibres was measured by
using a Sirius red stain. Constructs were washed three
times in PBS then fixed in 3.7% formaldehyde in PBS for
10 minutes. After washing in PBS 1 ml of 0.1% w/v Direct
Red 80 (Sigma–Aldrich) in saturated picric acid was added
and samples incubated for 18 hours at room temperature.
Constructs were rinsed with water until no further colour
was eluted. Samples were then dried overnight before
bound stain was eluted with 500 l 1:1 v/v 0.2 M NaOH
in methanol 1:1 for 15 min. Optical density at 490 nm
was then measured using a spectrophotometer (Bio-TEK,
NorthStar Scientific LTD, Leeds, UK).
2.6. Immunostaining for Keratin to Identify
Keratinocytes
Immunostaining of keratins using pancytokeratin anti-
body (ABD Serotec LTD, UK) was used to identify ker-
atinocytes in this study. Scaffolds cultured with cells were
fixed in 3.7% formaldehyde in PBS for 10 minutes and
washed 3 times with PBS. Samples were then permeabi-
lized with 0.5% w/v Triton X100 in PBS for 20 minutes at
room temperature. After blocking for 1 hour with 1% w/v
bovine serum albumin (BSA) in PBS, cells were incu-
bated at 40 C overnight with primary antibody (mouse
anti-cytokeratin, diluted 1:50 in 1% w/v BSA in PBS).
Samples were then washed with PBS and incubated with
biotinylated anti-mouse secondary antibody (1:1000 in
PBS) for 1.5 hours at room temperature. After wash-
ing with PBS samples were incubated for one hour with
Texas Red streptavidin (1:100 in PBS (Life Technologies,
USA)) and DAPI (4′,6-diamidino-2-phenylindole, 1 g/ml
in PBS (Life Technologies, USA). After further washing
with PBS (three times) fluorescence emission was visu-
alized with Axon ImageXpress (Axon instruments, USA)
fluorescence microscope. Micrographs were captured at
ex − 570 nm/em − 620 nm (pancytokeratin) and ex −
365 nm/em−460 nm (DAPI).
2.7. Cell Tracker Labelling of Keratinocytes and
Fibroblasts
Prior to seeding cells on scaffolds, CellTrackerTMGreen
and CellTrackerTMRed (Invitrogen Ltd, USA) were used
to label keratinocytes and fibroblasts respectively. Adher-
ent cells in culture flasks were rinsed with serum free
culture media before CellTracker™ Red or Green (50 g
in 5 ml of serum-free culture medium) was added to
culture flasks and incubated at 37 C for 45 minutes.
After washing with Greens medium, cells were incu-
bated in Greens medium for a further 30 minutes at
37 C. Cells were then seeding onto scaffolds as previ-
ously described. Labelled cells were imaged in an Axon
ImageExpress Microscope (Molecular Devices, Sunnyvale,
USA) at ex-570 nm/em-620 nm (Cell Tracker Red) and
ex-480 nm/em-533 nm (Cell Tracker Green).
2.8. Statistics
Statistical significance was calculated using Students
paired T -test, and p values of< 005 were considered sta-
tistically significant.
3. RESULTS
Tri-layered (PLLA-PHBV/PLLA-PLLA) and mono-
layered (PLLA) scaffolds were fabricated by electrospin-
ning (Fig. 1(B)), SEM photographs of sections through
each scaffold show the tri-layer scaffold to have a region
of intermingling of the micro- and nano-fibres in a
discrete layer approximately 20 m thick (Figs. 2(A)
J. Biomater. Tissue Eng. 4, 1–7, 2014 3
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Fig. 1. (A) Diagram of the dual polymer electrospinning rig used to
create tri-layered membrane. Microfibres (green) are electrospun on one
side of the mandrel while PHBV nanofibres (red) are spun at the same
time on the opposite side of the rotating mandrel. (B) SEM image of the
arrangement of micro (green) and nano (red) fibres in trilayer scaffold.
Scale bar represents 200 m.
and (B)) which is missing from the monolayer scaffold
(Figs. 2(C) and (D)). The central region of nano-fibres
(519± 5065 nm diameter) entangled with microfibers
(236 ± 015 m diameter) forms a continuous layer
region which appears to be almost nano-porous (pores
are 137 ± 0097 m whereas the remaining bulk of
the scaffold has pores of 1329± 224 m. Monolayer
PLLA scaffolds had uniformly randomly arranged fibres
(370±029 m diameter) with pores of 1939±149 m
and these parameters were not significantly different to
those of the microfibers of the tri-layer scaffold.
Keratinocytes and fibroblasts seeded on the upper and
lower surfaces respectively of mono- and tri-layer scaf-
folds surface proliferated over time as shown by MTT
staining of 7 and 14 day cultures and there were no sig-
nificant differences between cell growth on the tri- and
mono layer scaffolds (Fig. 3). SEM images show the cells
attached to both scaffolds, keratinocytes forming an epithe-
lial sheet covering the upper surface of the scaffolds by
14 days (Fig. 4). The lower surfaces of both tri and mono
layer scaffolds showed the presence of fibroblasts and the
suggestion of matrix proteins on the scaffold fibres.
This pattern of apparent cell segregation was also seen
in H&E sections where keratinocytes were seen to extend
from the upper surface of the scaffold down to the interwo-
ven barrier and no further, and the lower portion has some
but few fibroblasts (Fig. 5(A)). Sections of monolayer
Fig. 2. SEM of sections through tri-layer and monolayer scaffolds. (A)
and (B) show the micro/nano fibres in the central barrier region of the
scaffold. (C) and (D) detail the monolayer scaffold composed of PLLA
microfibers. Scale bars as shown in each individual photograph.
scaffolds showed no such organization suggesting that
cells were unable to cross this central barrier region of
the tri-layer scaffolds but were free to colonise the entire
thickness of the monolayer scaffolds (Fig. 5(B)). (Please
note that paraffin fixing and dewaxing using solvents dis-
solves most of the scaffolds hence imaging results by this
method is challenging compared to SEM and immunos-
taining).
To further verify segregation of cells, cell tracker loaded
cells were added to scaffolds on opposing sides of the
interwoven barrier, and their ability to cross the thick-
ness of each scaffold assessed. Figure 6 shows cell tracker
labelled cells were found to be segregated by the inter-
woven barrier of the tri-layer scaffold as keratinocytes
(labelled with green CellTracker™) were only found on
the upper surface of tri-layer scaffolds while in mono-
layer scaffolds they could also be seen on the lower sur-
face. Similarly fibroblasts (labelled with green cell tracker)
could only be found in the lower region of tri-layer scaf-
folds but were seen throughout the monolayer scaffold.
Fig. 3. Viability of keratinocytes and fibroblasts cultured on tri-layer
and monolayer scaffold for 7 and 14 days. Results shown represent
mean±SD (n= 6).
4 J. Biomater. Tissue Eng. 4, 1–7, 2014
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Fig. 4. SEM images of keratinocytes and fibroblasts cultured on tri-
layer and monolayer scaffold for 7 and 14 days, upper and lower surfaces
of tri-layer and monolayer scaffolds. Scale bars= 100 m.
Positive identification of keratinocytes was made by
immunostaining of the keratinocytes for keratin produc-
tion and this confirmed their location in the upper part of
the tri-layer and throughout the monolayer scaffolds. An
image showing expression of pancytokeratin on the scaf-
fold seeded with keratinocytes is presented in Figure 7.
Cells positive for pan-cytokeratin were not seen in the
lower layers of tri-layer scaffolds–only the DAPI stained
nuclei of pancytokeratin negative cells (fibroblasts) were
seen. Again, as before, such segregation was not seen
in monolayer scaffolds. Total collagen production by cells
on the scaffolds increased over time on each scaffold, as
Fig. 5. H&E sections of (A) PLLA-PHBV/PLLA-PLLA tri-layer and
(B) PLLA monolayer seeded with keratinocytes and fibroblasts after
14 days of culture. 100x magnification, scale bar= 200 m.
Fig. 6. Celltracker™ labelled keratinocytes (green) and fibroblasts (red)
cultured on tri-layer and monolayer scaffolds for 7 and14 days. 100x
magnification scale bar= 600 m.
Fig. 7. Pancytokeratin expression (red) by keratinocytes cultured on tri-
layer and monolayer scaffolds for 7 and 14 days, all cells were counter-
stained with DAPI (blue). 100x magnification, scale bar= 600 m.
seen by the intense red staining seen in all cell seeded
scaffolds. However there was significantly more collagen
found on the tri-layer scaffolds compared to the mono-
layer scaffolds at both 7 and 14 days of culture (P < 005,
Fig. 8).
Fig. 8. Collagen deposition measured using Sirius red staining of co-
cultures of keratinocytes and fibroblasts on tri-layer scaffolds and mono-
layer scaffolds after 7 and 14 days. Results shown represent mean±SD
(n= 6).
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4. DISCUSSION
Our aim was to produce a biodegradable scaffold contain-
ing a basement membrane substitute that would simplify
the production of 3D tissue engineered skin for clinical
use.
In this study we have shown that a simple barrier can
be made within an electrospun scaffold to recreate the cell
segregation/barrier function of the basement membrane of
the human dermis.
This allowed the culture of keratinocytes and fibroblasts
in conditions where they could have communication via
cytokine signalling but remain as separate populations of
cells. Synthetic polymer scaffolds are increasingly com-
mon in tissue engineering, providing a surface for cell
growth and a mechanical support structure for the devel-
oping tissue. However biological scaffolds such as de-
epidermised dermis (DED) or amnion provide more than
a simple scaffold, they possess attachment proteins which
provide location and behavioural cues for the cells grow-
ing on them - the basement membrane.
One function of the basement membrane is to provide
segregation for cells to prevent one cell type over grow-
ing the other—but still allowing cytokine crosstalk—which
is critical in the creation of a fully stratified functional
epidermis. This could be partially provided by selectively
coating the scaffold with matrigel—however this would
preclude the clinical use of such scaffolds due to the ani-
mal cancer cell line origin (a hamster fibrosarcoma) of the
BM proteins in matrigel.2021
The current study focuses on the fabrication of a
tri-layered electrospun scaffold using poly lactic acid/
poly hydroxybutyrate-co-hydroxyvalerate/polylactic acid
(PLLA-PHBV/PLLA-PLLA) exploring the potential of an
interwoven nano-fibrous PHBV/PLLA layer to act as a
basement membrane substitute for the organization of epi-
dermal and dermal cells for 3D skin construction.
The potential of the tri-layered electrospun scaffolds for
3D skin construction was evaluated by observing their
ability to support both the adhesion and proliferation of
keratinocytes and fibroblasts after culturing on their sur-
faces for 7 and 14 days. Scanning electron microscopy
images demonstrated adhesion and proliferation of epider-
mal and dermal cells on the tri-layered and mono-layered
scaffold and the surface coverage after 7 days and 14 days
on the tri-layered scaffold was the same as that on the
control mono-layered PLLA scaffolds.
Images of the cross-section of the tri-layered scaffold
show that the PHBV nano-fibrous layer of the tri-layered
scaffold may mimic the basement membrane, the nano-
fibrous layer of the tri-layered scaffold obstructed the cel-
lular migration of keratinocytes and fibroblasts from the
two opposite PLLA scaffold layers. While the viability
of cells on the scaffolds was not affected by the pres-
ence of the nano-porous PHBV layer, there was a small
but significant increase in collagen deposition on the tri-
layered scaffold. This deposition would be the start of
the skin cells remodelling the scaffold from a synthetic
scaffold to a collagenous tissue. It is known that when
keratinocytes and fibroblasts are co-cultured they begin to
produce basement membrane proteins.22 However in our
experience based on looking at the formation of hemi-
desmosomes in reconstructed skin based on decellularised
dermis they failed to achieve any structural organization
even after 3 weeks in vitro unless there was some basement
membrane already present in which case they were able
to form hemi-desmosomes which help anchor the ker-
atinocytes to the underlying dermal collagen.23 In the cur-
rent study we have provided cells with a physically dense
nano-fibrous mesh as a basement membrane substitute.
Alternative approaches of introducing natural ECM pro-
teins may well work but are rarely going to be suitable
for scale - up for clinical use for reasons of cost and
more importantly regulatory concerns about safety will
mean that such ECM proteins must be sourced so they
are no risk to the patient-implying recombinant proteins
or synthesised peptide sequences from these proteins. Our
approach is simpler and cheaper and poses no clinical
risks.
In scaffolds where there is no barrier to growth of ker-
atinocytes, epithelial growth may ultimately fill up the
entire scaffold usurping the fibroblasts-as seen in HACAT
seeded mono- but not tri-layer scaffolds (data not shown).
The cell impermeable barrier creates a niche or refuge
for fibroblasts preventing displacement and ensuring their
continued presence. This preserves a region which can
be remodelled into a collagen and fibroblast rich der-
mal replacement. The presence of fibroblasts within the
scaffold is essential to support the growth of a strati-
fied and differentiated epithelium, the crosstalk between
epidermal keratinocytes and fibroblasts is needed for tis-
sue remodelling.2425 In wound healing, the mid- and
late phases are dominated by keratinocyte and fibrob-
last interactions which drive the formation of granulation
tissue.26 The PHBV layer created here is only 20 m
across, with pores of just over 1 m has previously been
shown to have a porosity 60% porous,18 and we sug-
gest that this would not prevent cytokine keratinocyte—
fibroblast crosstalk which normally occurs across the
papillary dermis.
The creation of a functioning epithelium supported by
fibroblasts within a dermal matrix is a concept of great
interest in the field of regenerative medicine. In the case
of large burns where the available skin for autograft-
ing is limited, a scaffold capable of being seeded with
autologous cells to recreate a functional epithelium would
assist surgeons in the management of these patients and
reduce the use of allograft material. The majority of bio-
engineered skin substitutes are comprised of freeze-dried
biopolymer sponges populated with donor dermal fibrob-
lasts alone or in conjunction with keratinocytes.2728 The
scaffold presented here is made from fibres known to be
6 J. Biomater. Tissue Eng. 4, 1–7, 2014
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biocompatible and biodegradable over a 1–2 year period29,
however the rate of degradation can be increased by using
PLLA:Polyglycolic acid blends and by sterilisation post
production with gamma irradiation. Ideally one wants scaf-
folds to breakdown without causing any inflammatory
problems at a rate to match the rate of remodelling or
replacement by the host cells.30 An electrospun scaffold of
biodegradable biocompatible electrospun fibres would be
a promising material providing both a functional epithe-
lium and a protected fibroblast rich dermal niche. Such
organization is essential to skin development and effective
wound healing. The creation of a stratified epithelium is
essential, providing a barrier to fluid loss and infection.
Thus, to provide the greatest benefits to patients both the
dermal and epidermal components need to be viable and
well organized.
5. CONCLUSIONS
Our study demonstrates the possibilities of making a com-
posite construct with a tri-layered scaffold containing an
epidermal layer with an artificial basement membrane
and underlying dermal structure. The nano-fibrous PHBV
membrane of the tri-layered electrospun scaffold segregat-
ing keratinocytes and fibroblasts did not have any negative
impact on the attachment and proliferation of keratinocytes
and fibroblasts. PHBV nano-fibres were found to promote
keratinocyte adhesion and proliferation compared with the
mono-layered PLLA surface with keratinocytes and fibrob-
lasts on the upper and lower surface of the scaffold. Fur-
ther work with this trilayer scaffold will now focus on
modifying the dermal region of the scaffold to promote
rapid neovascularization when transplanted.
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